Asset Allocation & Management Company’s Pfizer PFE Stock Holding History

Asset Allocation & Management Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,027	Closed	-$551K	–	61
2023 Q2	$551K	Sell	15,027 -2,772	-16%	-$108K	0.22%	45
2023 Q1	$726K	Hold	17,799	–	–	0.29%	49
2022 Q4	$912K	Sell	17,799 -5,700	-24%	-$273K	0.35%	40
2022 Q3	$1.03M	Hold	23,499	–	–	0.42%	38
2022 Q2	$1.23M	Hold	23,499	–	–	0.51%	26
2022 Q1	$1.22M	Hold	23,499	–	–	0.44%	40
2021 Q4	$1.39M	Buy	+23,499	New	+$1.16M	0.47%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Asset Allocation & Management Company's PFE Position: Q3 2023 in Review

Asset Allocation & Management Company sold out of Pfizer (PFE) in Q3 2023, closing a stake of 15,027 shares — an estimated $551K sold.

Asset Allocation & Management Company first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $1.39M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Asset Allocation & Management Company reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Asset Allocation & Management Company sold 15,027 Pfizer shares in Q3 2023, an estimated $551K.
Asset Allocation & Management Company first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
Asset Allocation & Management Company's Pfizer position peaked at $1.39M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Asset Allocation & Management Company's 13F filing for Q3 2023, filed 17 Oct 2023.